Experience with the use of a ketogenic diet with type 1 glucose transporter deficiency (De Vivo disease)

De Vivo disease is characterized by early epileptic encephalopathy, delayed psychomotor development, spasticity, the formation of microcephaly, ataxia, dysarthria, alternating hemiplegia, and a decrease in glucose and lactate levels in the cerebrospinal fluid. Epilepsy is pharmacoresistant and the t...

Full description

Bibliographic Details
Main Author: N. G. Lyukshina
Format: Article
Language:Russian
Published: ABV-press 2021-11-01
Series:Русский журнал детской неврологии
Subjects:
Online Access:https://rjdn.abvpress.ru/jour/article/view/377
_version_ 1826557979357347840
author N. G. Lyukshina
author_facet N. G. Lyukshina
author_sort N. G. Lyukshina
collection DOAJ
description De Vivo disease is characterized by early epileptic encephalopathy, delayed psychomotor development, spasticity, the formation of microcephaly, ataxia, dysarthria, alternating hemiplegia, and a decrease in glucose and lactate levels in the cerebrospinal fluid. Epilepsy is pharmacoresistant and the therapy for this syndrome is the ketogenic diet (until the time when will development of genetic targeted therapy). In GLUT1 deficiency syndrome, mutations are found in the SLC2A1 gene that lead to a decrease in glucose transport across the cell membrane.  The “classic” ketogenic diet is a special high-fat, low-carbohydrate diet that helps to control seizures in some people with epilepsy. It is prescribed by a physician and carefully monitored by a dietitian. It is usually used in children with seizures that do not respond to medications. It is stricter than the modified Atkins diet, requiring careful measurements of calories, fluids, and proteins. Foods are weighed and measured. Normal dietary fats, which are used predominantly in the classical ketogenic diet, consist of a mixture of mainly long chain triglyceride (LCT) fats with a small amount of short and medium chain triglyceride (MCT) fats. The MCT ketogenic diet uses a fat supplement that consists only of MCT fats (MCT oil).
first_indexed 2024-04-10T01:31:45Z
format Article
id doaj.art-9e48dfad8a774336ad75ec5bcf7db9c6
institution Directory Open Access Journal
issn 2073-8803
2412-9178
language Russian
last_indexed 2025-03-14T08:37:12Z
publishDate 2021-11-01
publisher ABV-press
record_format Article
series Русский журнал детской неврологии
spelling doaj.art-9e48dfad8a774336ad75ec5bcf7db9c62025-03-02T12:58:02ZrusABV-pressРусский журнал детской неврологии2073-88032412-91782021-11-01163636810.17650/2073-8803-2021-16-3-63-68255Experience with the use of a ketogenic diet with type 1 glucose transporter deficiency (De Vivo disease)N. G. Lyukshina0MIDEAL LLCDe Vivo disease is characterized by early epileptic encephalopathy, delayed psychomotor development, spasticity, the formation of microcephaly, ataxia, dysarthria, alternating hemiplegia, and a decrease in glucose and lactate levels in the cerebrospinal fluid. Epilepsy is pharmacoresistant and the therapy for this syndrome is the ketogenic diet (until the time when will development of genetic targeted therapy). In GLUT1 deficiency syndrome, mutations are found in the SLC2A1 gene that lead to a decrease in glucose transport across the cell membrane.  The “classic” ketogenic diet is a special high-fat, low-carbohydrate diet that helps to control seizures in some people with epilepsy. It is prescribed by a physician and carefully monitored by a dietitian. It is usually used in children with seizures that do not respond to medications. It is stricter than the modified Atkins diet, requiring careful measurements of calories, fluids, and proteins. Foods are weighed and measured. Normal dietary fats, which are used predominantly in the classical ketogenic diet, consist of a mixture of mainly long chain triglyceride (LCT) fats with a small amount of short and medium chain triglyceride (MCT) fats. The MCT ketogenic diet uses a fat supplement that consists only of MCT fats (MCT oil).https://rjdn.abvpress.ru/jour/article/view/377developmental encephalopathyepilepsygeneticsglut1 deficiencydevelopmental delayketogenic dietmct
spellingShingle N. G. Lyukshina
Experience with the use of a ketogenic diet with type 1 glucose transporter deficiency (De Vivo disease)
Русский журнал детской неврологии
developmental encephalopathy
epilepsy
genetics
glut1 deficiency
developmental delay
ketogenic diet
mct
title Experience with the use of a ketogenic diet with type 1 glucose transporter deficiency (De Vivo disease)
title_full Experience with the use of a ketogenic diet with type 1 glucose transporter deficiency (De Vivo disease)
title_fullStr Experience with the use of a ketogenic diet with type 1 glucose transporter deficiency (De Vivo disease)
title_full_unstemmed Experience with the use of a ketogenic diet with type 1 glucose transporter deficiency (De Vivo disease)
title_short Experience with the use of a ketogenic diet with type 1 glucose transporter deficiency (De Vivo disease)
title_sort experience with the use of a ketogenic diet with type 1 glucose transporter deficiency de vivo disease
topic developmental encephalopathy
epilepsy
genetics
glut1 deficiency
developmental delay
ketogenic diet
mct
url https://rjdn.abvpress.ru/jour/article/view/377
work_keys_str_mv AT nglyukshina experiencewiththeuseofaketogenicdietwithtype1glucosetransporterdeficiencydevivodisease